New Gurugram centre is India's first clinical Prevention Centre with 2 state of the art MRI machines and a capacity of 2000 scans a month
Study of 78,000 diagnostic investigations by Mahajan Imaging identifies over 13,000 abnormal or critical findings, highlighting silent health risks among working-age men
The expanded approval covers children and teens with chronic conditions that increase vulnerability to pneumococcal infections
State-of-the-art facility brings next-generation imaging and minimally invasive neurointerventional capabilities to Eastern India
Union Health Minister calls for heightened vigilance, stronger public awareness campaigns, and district-specific action plans for the high-transmission season
Company introduces bioequivalent version of Edarbi for hypertension treatment following U.S. FDA approval; product recorded annual U.S. sales of USD 53.5 million
Highlights India’s advances in pharmacopoeial science, regulatory standards, and global harmonization efforts at the 16th International Meeting of World Pharmacopoeias
Approval paves the way for expansion in North America’s growing vascular access market, with innovative SlipStream technology designed to simplify catheter insertion and enhance patient care
Expanded indication makes Stelo the first FDA-cleared OTC CGM for children aged two years and older with diabetes or prediabetes
Production at Vadodara facility strengthens Make in India initiative, enhances access to diagnostic testing, and supports preventive healthcare across the country
Subscribe To Our Newsletter & Stay Updated
